PLX
Protalix BioTherapeutics, Inc.2.37post−$0.00 (−0.21%)at close +$0.00 (+0.00%)
as of 19:59:51 UTCnext report Aug 12 · 7d
Earnings Room‹ back to PLX
The report
fiscal Q2 2026 · from the company's noticeAug 12before open7days out
Expected movement
market-implied · at the Aug 4 close±22.1%is what the chain prices for this report itself, with the ordinary drift of the days around it taken out. Not a view we hold.
The full straddle prices ±23.4% over the 17 days to expiry; the rest of that is everyday movement, which the chain prices at 50% annualized.
expiry Aug 21 · first after the reportATM strike 2.5straddle 0.65ATM IV 154% vs 102% at Sep 18× 0.85 straddle-to-rangespot 2.37
Blast radius
1 linked · N-PORT + EDGARIf PLX moves ±23.4% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color2/8reports moved further than the options market had pricedtypically ±13.9% realized vs ±25.1% priced
May 13 '26±17.0%→+1.1%×0.06
Mar 18 '26±15.2%→−20.8%×1.37
Nov 13 '25±28.3%→−9.8%×0.35
Aug 14 '25±43.2%→−5.6%×0.13
May 9 '25±14.0%→−40.5%×2.88
Mar 17 '25±15.1%→+9.4%×0.62
Nov 14 '24±18.5%→+13.7%×0.74
Aug 14 '24±49.4%→−10.6%×0.21
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported 0.22 · rev $34M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.